Insider Trading February 19, 2026

Saba Capital Reduces Stake in BlackRock ESG Capital Allocation Term Trust, Executes $2.4M Sale

Two-day disposal trims holdings but leaves Saba as a sizable long-term shareholder in ECAT

By Jordan Park ECAT
Saba Capital Reduces Stake in BlackRock ESG Capital Allocation Term Trust, Executes $2.4M Sale
ECAT

Saba Capital Management, L.P., identified as a 10% holder of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), sold 159,289 shares across February 17 and 18. The two transactions generated roughly $2.4 million in proceeds, with executed prices ranging from $15.06 to $15.11 per share. After the sales, Saba retained more than 23.7 million ECAT shares.

Key Points

  • Saba Capital, a 10% holder of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), sold a total of 159,289 shares on February 17 and 18.
  • The two transactions generated approximately $2.4 million, with executed prices between $15.06 and $15.11 per share.
  • After the sales, Saba retained a substantial position, holding 23,744,358 shares of ECAT, indicating continued material ownership in the trust.

Saba Capital Management, L.P. executed two share sales of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT) common stock on consecutive days in mid-February. The firm, which holds a ten percent ownership stake in the trust, disposed of a combined 159,289 shares on February 17 and February 18, generating total proceeds of approximately $2.4 million.

The first transaction occurred on February 17, when Saba sold 113,401 shares at $15.06 apiece. Following that sale, the firms reported holding stood at 23,790,246 shares. On February 18, Saba sold an additional 45,888 shares at $15.11 per share, leaving it with 23,744,358 shares after the second transaction.

The two trades carried executed prices in a narrow band - between $15.06 and $15.11 - and together account for the full 159,289 shares sold over the two-day span. The aggregate value of those transactions was reported as $2.4 million.


Context and holdings: The filings show Saba as a significant holder of ECAT, retaining more than 23.7 million shares after these dispositions. The disclosure of the sales documents the change in the firms reported position but does not include commentary or an explanation for the trades.

What is explicitly known from the filings:

  • Saba Capital is a ten percent owner of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT).
  • On February 17, Saba sold 113,401 ECAT shares at $15.06 per share and held 23,790,246 shares afterward.
  • On February 18, Saba sold 45,888 ECAT shares at $15.11 per share and held 23,744,358 shares afterward.
  • The combined sales of 159,289 shares totaled $2.4 million.

Reporting limitations: The transaction records themselves provide the quantities, prices, dates, and resulting holdings, but they do not include motive or further detail regarding the firms strategic intent. No additional commentary, such as whether the trades were part of a planned rebalancing or related to other portfolio moves, is available in the filings summarized here.

Risks

  • The filings do not state a reason for the sales, leaving the motive for the transactions unclear - this uncertainty affects interpretation by investors and market participants.
  • Further sales or changes in Sabas reported position are not documented here, so future shifts in ownership or trading activity remain unknown.
  • The information available is limited to quantities, prices, and resulting holdings; absence of additional context constrains assessment of potential market or portfolio impacts.

More from Insider Trading

Bank of the James Director Adds $20,412 in Shares; Co-Founder Retires After Long Tenure Feb 20, 2026 Rogers Corp Director Disposes of 8,000 Shares; Stock Near Yearly High After Strong Quarter Feb 20, 2026 Nicolet Bankshares Director Executes Stock Sales and Option Exercise Totaling Over $2 Million Feb 20, 2026 CME Group Director Disposes $91,770 in Shares as Company Advances New Products Feb 20, 2026 Espey MFG Director Sells $138,962 in Stock as Audit Committee Chair Changes Feb 20, 2026